Providence Therapeutics Company
Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.
Technology:
RNA
Industry:
RNA
Headquarters:
Toronto, Ontario, Canada
Founded Date:
2015-01-01
Employees Number:
11-50
Investors Number:
1
Total Funding:
149500000
Last Funding Date:
2021-12-07
Last Funding Type:
Grant
Register and Claim Ownership